Global Health & Biotech Archives | Page 5 of 287 | Be Korea-savvy

Archive by category Global Health & Biotech

Philips brings AI into the procedure room to assist doctors during heart valve repair

Philips brings AI into the procedure room to assist doctors during heart valve repair

November 17, 2025 Innovation uses AI to track and visualize tiny repair devices* through the beating heart, helping clinicians navigate in 3D with enhanced clarity and confidence**   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced DeviceGuide, an AI-powered device tracking* solution that assists physicians during one [...]

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts

Curium Biopharma will continue to lead discovery and new product development  Strategic move aims to accelerate biopharma innovation and revolutionize the diagnosis and treatment of cancer Curium International headquarters remain in Paris, France, while the United States headquarters are in St Louis, Missouri ST. LOUIS, Nov. 17, 2025 (Korea Bizwire) – Curium, a company dedicated [...]

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal

Ziihera® plus chemotherapy showed a clinically meaningful and statistically significant improvement in PFS versus trastuzumab and chemotherapy, and a clinically meaningful effect with a strong trend toward statistical significance for OS at the first OS interim analysis Ziihera plus Tevimbra® (tislelizumab) and chemotherapy demonstrated clinically meaningful and statistically significant improvements in OS and PFS versus trastuzumab and [...]

Positioning Barbados as the Caribbean’s Life Sciences Hub

Positioning Barbados as the Caribbean’s Life Sciences Hub

EarlyHealth City to Anchor US$200 Million Investment BRIDGETOWN, Barbados, Nov. 14, 2025 (Korea Bizwire) – Export Barbados (BIDC) and EarlyHealth Group (EHG), headquartered in Dubai, United Arab Emirates, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados, a US$200 Million world-class pharmaceutical and life sciences cluster earmarked for Newton, Christ Church. The [...]

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

New York, NY and Woburn, MA, Nov. 10, 2025 (Korea Bizwire) – Azurity Pharmaceuticals names Ogilvy Health as public relations and marketing agency of record. Ogilvy Health’s mandate will focus on reimagining Azurity’s brand story centered on patient commitment and pioneering growth. The agency will also enhance Azurity’s external visibility – both online and offline [...]

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets Demonstrate Positive Real-world Impact, with Patients Reporting Improvement in Involuntary Movements and Activities of Daily Living

In a new cohort of 27 adults from the IMPACT-TD Registry, up to 77% of participants reported improvements in aspects of their lives impacted by tardive dyskinesia (TD) while taking AUSTEDO or AUSTEDO XR Most (85%) participants taking AUSTEDO or AUSTEDO XR in conjunction with their mental health medications reported that their mental health condition [...]

Carestream to Showcase Award-Winning Innovation and New Products at RSNA 2025

Carestream to Showcase Award-Winning Innovation and New Products at RSNA 2025

Rochester, N.Y., Nov. 05, 2025 (Korea Bizwire) – Carestream Health is excited to showcase the award-winning, customer-first solutions behind its versatile portfolio of X-ray imaging solutions at the Radiologic Society of North America (RSNA) Annual Conference from November 30-December 4, 2025, in Chicago. Attendees can visit Booth #2154 in the South Hall to learn how [...]

Teva’s Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

Teva’s Innovative Portfolio Drives 11th Consecutive Quarter of Growth in Q3 2025; Increases 2025 Outlook for Austedo® and Non-GAAP EPS

For an accessible version of this Press Release, please visit www.tevapharm.com Teva reports revenues of $4.5 billion in the third quarter of 2025, an increase of 3% year-over-year (YoY) in U.S. dollars or 1% in local currency (LC). Excluding Japan BV in Q3 2024, revenues increased 5% in U.S. dollars or 3% in LC. United [...]

MedPro Healthcare Staffing’s Patty Jeffrey, RN, Honored at the 2025 Excellence in Healthcare Awards

MedPro Healthcare Staffing’s Patty Jeffrey, RN, Honored at the 2025 Excellence in Healthcare Awards

Sunrise, Florida, Nov. 04, 2025 (Korea Bizwire) – MedPro Healthcare Staffing proudly announces that Patty Jeffrey, RN, Executive Vice President of International Operations, will be honored at the 2025 Excellence in Healthcare Awards, hosted by the Greater Fort Lauderdale Chamber of Commerce Healthcare Council in partnership with Sylvester Comprehensive Cancer Center and Baptist Health South Florida. “It’s [...]

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

Boehringer Ingelheim and CDR-Life Expand Collaboration Efforts with Global Licensing Agreement for CDR111, an Antibody-Based Trispecific M-gager® for Autoimmune Diseases

New deal builds on the success of a longstanding partnership in retinal health and the potential of CDR-Life’s unique antibody fragment-based platform     Agreement provides potential for up to approx. USD 570 million in total payments including approx. USD 48 million in upfront and near-term payments, plus tiered royalties  Ingelheim, Germany and Zurich, Switzerland – November 4, 2025 – Boehringer Ingelheim and CDR-Life, [...]